Call for Papers: AI in Immune-Related Adverse Events (irAEs) – AI in Precision Oncology
AI in Precision Oncology shared a post on LinkedIn:
“Join us in advancing this critical field! Learn more and submit your research here.
Artificial Intelligence (AI) is transforming the way we understand and manage immune-related adverse events (irAEs) in cancer immunotherapy. From early detection to predictive modeling, AI-driven insights have the potential to revolutionize patient care.
We invite researchers to submit original studies and reviews exploring the role of AI in irAEs, including:
- Predictive analytics and risk stratification
- AI-driven diagnosis and monitoring
- Novel computational models for irAEs
- Integrating AI with clinical decision-making
Submission Deadline: October 30, 2025.”
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare and ACCC President-Elect, shared a post by AI in Precision Oncology, adding:
“We’d love to see your manuscripts on these topics or others, especially original research or reviews.
Message me if you have ideas for some editorial front matter or interesting takes you’d like to get out into the world.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023